Analysed IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) News Sources
Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call Highlights: Strong LINZESS Growth ...
06-08-2026
yahoo.com
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients
14-07-2026
yahoo.com
Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum
03-07-2026
yahoo.com
Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed?
07-08-2026
yahoo.com
What is the current price of IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ)?
The current price of IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) is $4.04.
IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) absolute price change since previous trading day?
The absolute price change of IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) since the previous trading day is $0.07.
IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) percentage price change since previous trading day?
The percentage price change of IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) since the previous trading day is 1.7632%.
What is the most recent average sentiment score for IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ)?
The most recent average sentiment score for IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ)?
The most recent sentiment for IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) is .
SEC-8K** Filing Available For IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.